The chronic refractory cough market is witnessing robust expansion driven by increasing prevalence rates and unmet therapeutic needs. Innovations in targeted therapies and enhanced diagnostic protocols have fueled heightened interest, shaping the market dynamics profoundly. This blog presents a comprehensive chronic refractory cough market analysis encompassing market size, segments, consumer...

The clinical trial software industry is witnessing significant transformation driven by technological advancements and increased demand for streamlined drug development processes. With growing complexities in clinical trials and a focus on data integrity, this sector is poised for accelerated growth, aligned with dynamic market trends and emerging opportunities.Market Size and Overview The...

The global Abdominal Aortic Aneurysm (AAA) Treatment Market is expected to witness steady growth as healthcare providers increasingly adopt advanced surgical and minimally invasive endovascular procedures to treat abdominal aortic aneurysms. According to Future Market Insights (FMI), the market is projected to expand from USD 2.4 billion in 2026 to USD 4.1 billion by 2036, registering a CAGR of...

Transcranial stimulation devices are advanced non-invasive neuromodulation systems designed to stimulate targeted areas of the brain using controlled magnetic or electrical impulses. These technologies are increasingly used to manage a wide range of neurological and psychiatric conditions, including major depressive disorder, chronic pain, Parkinson's disease, stroke recovery, traumatic brain...

Transcranial stimulation devices are innovative, non-invasive brain stimulation technologies that use magnetic fields or gentle electrical currents to influence neural activity in specific regions of the brain. The primary types include Transcranial Magnetic Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS). These therapies are widely used to manage conditions...

The global AI in Clinical Trials Market advances in generative AI for protocol authoring, digital twins, synthetic control arms, natural language processing for EHR matching, and predictive outcome modeling are transforming how trials are designed and executed. According to Business Market Insights, the AI in Clinical Trials Market size was valued at US$ 4.10 Billion in 2025 and is projected to...

The AI in Clinical Trials market is poised for significant transformation as artificial intelligence integrates deeper into the clinical development landscape, driving efficiency and accuracy. This industry is rapidly evolving through innovative applications of AI that optimize trial design, patient recruitment, and data analysis, shaping the future of clinical research with unprecedented scale...

  AI in Genomics Market to Reach USD 21.08 Billion by 2034, Growing at 39.74% CAGR According to a report by Polaris Market Research, the global AI in Genomics Market was valued at USD 1.04 billion in 2025 and is projected to reach USD 21.08 billion by 2034. The market is expected to expand at a CAGR of 39.74% from 2026 to 2034. Growth is supported by rising adoption of artificial...

According to Future Market Insights (FMI), The global ampoules packaging market is witnessing strong momentum as pharmaceutical manufacturers increasingly prioritize sterile, tamper-proof, and high-barrier packaging solutions for injectables, vaccines, and biologic therapies. Rising healthcare expenditure, expanding vaccine programs, and rapid growth in biologics are significantly increasing...

The global amyloidosis treatment market is poised for strong growth as healthcare systems increasingly prioritize rare disease management, precision medicine, and advanced therapeutic interventions. Valued at USD 6.2 billion in 2025, the market is projected to reach USD 12.9 billion by 2035, growing at a 7.5% CAGR during the forecast period. Growth is increasingly driven by therapeutic...

NEWARK, Del., July 11, 2026 — The global Healthcare Antibody Quantification Market is expected to witness robust growth as biologics development, immunology research, and precision diagnostics continue expanding across pharmaceutical and biotechnology industries. According to Future Market Insights (FMI), the market is projected to grow from USD 7.8 billion in 2026 to USD 17.0 billion by...

Vagus nerve stimulation (VNS) devices are advanced therapeutic medical devices that deliver gentle electrical impulses to the vagus nerve to modulate neural activity and improve communication between the brain and the body. They are primarily used to manage neurological and psychiatric conditions such as drug-resistant epilepsy, treatment-resistant depression, chronic pain, migraines, stroke...

Vagus nerve stimulation (VNS) devices are innovative neuromodulation systems that deliver controlled electrical pulses to the vagus nerve to help regulate brain function and support communication within the nervous system. These devices are used to treat various neurological and psychiatric disorders, including drug-resistant epilepsy, treatment-resistant depression, chronic migraines,...

Vagus nerve stimulation (VNS) devices are specialized neuromodulation systems that deliver gentle electrical impulses to the vagus nerve to regulate abnormal nerve activity and enhance communication between the brain and the body's organs. This therapy is designed to improve neurological function and provide long-term symptom relief for patients with chronic neurological and psychiatric...

Vagus nerve stimulation (VNS) devices are advanced therapeutic devices that send carefully controlled electrical signals to the vagus nerve to influence specific neurological functions. They are used to support the management of various neurological and health conditions, particularly in cases where conventional treatments may not deliver sufficient therapeutic benefits. VNS technology is...

Vagus nerve stimulation (VNS) devices are advanced therapeutic devices that send carefully controlled electrical signals to the vagus nerve to influence specific neurological functions. They are used to support the management of various neurological and health conditions, particularly in cases where conventional treatments may not deliver sufficient therapeutic benefits. VNS technology is...

Deep brain stimulation (DBS) devices are implantable neuromodulation technologies designed to treat neurological disorders by delivering precisely controlled electrical impulses to targeted areas of the brain. These impulses help normalize abnormal neural activity, providing symptom relief for patients with conditions such as Parkinson's disease, essential tremor, dystonia, epilepsy, and...

Deep Brain Stimulation (DBS) devices are implantable neurostimulation systems that use carefully controlled electrical impulses to stimulate targeted areas of the brain. This therapy helps regulate abnormal brain signals associated with movement disorders and certain neurological or psychiatric conditions, providing symptom relief for patients who do not respond adequately to medication. DBS is...

Deep Brain Stimulation (DBS) devices are implantable neurostimulation systems that use carefully controlled electrical impulses to stimulate targeted areas of the brain. This therapy helps regulate abnormal brain signals associated with movement disorders and certain neurological or psychiatric conditions, providing symptom relief for patients who do not respond adequately to medication. DBS is...

Veterinary Magnetic Resonance Imaging (MRI) refers to a non-invasive diagnostic imaging technology used to capture detailed images of an animal’s internal anatomy. It operates through magnetic fields and radiofrequency energy to produce high-resolution images of soft tissues, including the brain, spinal cord, muscles, joints, and other organs. Veterinary MRI assists clinicians in...